首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Drugs in research & development

缩写:

ISSN:1174-5886

e-ISSN:1179-6901

IF/分区:2.1/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引586
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Biao Yu,Kangkang Mei,Didi Zhan et al. Biao Yu et al.
Background and objectives: Vancomycin (VCM) pharmacokinetic parameters vary widely between individuals. Existing models developed domestically and internationally may not apply universally because of differences in patien...
Yinglin Yang,Jiejing Kai,Duo Lv et al. Yinglin Yang et al.
Background and objectives: Flunarizine, a selective calcium channel blocker with vasodilatory and neuroprotective effects, is a mainstay for migraine prophylaxis and vertigo management. This study aimed to compare the bio...
Sandrella Hamdan,Samuel Adelou,Sébastien Jungo et al. Sandrella Hamdan et al.
Background and objectives: Performing medical procedures on children can often be challenging because of the anxiety that these procedures may induce, the need for immobility that they may require, or age-related developm...
Qinjiao Fu,Chunqi Huang,Yuan Yuan et al. Qinjiao Fu et al.
Background and objective: Nitroglycerin, a cornerstone therapy for acute angina pectoris, achieves rapid symptom relief through sublingual administration by bypassing hepatic first-pass metabolism. This study aimed to inv...
Shamia L Faison,Joelle Batonga,Thangam Arumugham et al. Shamia L Faison et al.
Background and objective: Dordaviprone (ONC201) is a novel small molecule with antitumor effects in patients with glioma. The major elimination pathway of dordaviprone is metabolism via cytochrome P450 (CYP) 3A4. This stu...
Jigang Zhang,Mingjian Zhang,Wenyuan Xue et al. Jigang Zhang et al.
Background and objective: This study aimed to evaluate the bioequivalence of a novel prefilled recombinant human follicle-stimulating hormone (rh-FSH) injection (GenSci008) compared with the existing rh-FSH for injection ...
Sven Hartmann,Jonas Rosendahl,Amy Todd et al. Sven Hartmann et al.
Introduction: Commercially available pancreatic enzyme replacement therapy (PERT) preparations differ significantly in their physical and enzyme properties, raising concern about the interchangeability of these preparatio...
Alexandra Papaelias,Darcy Lidington,Steffen-Sebastian Bolz Alexandra Papaelias
Background and objective: Lumacaftor is an active ingredient in the US Food and Drug Administration-approved combination medication Orkambi®, which is used for treating cystic fibrosis. Experimental evidence suggests tha...
Xiang-Yang Xie,Yuan Zeng,Zhi-Long Chen et al. Xiang-Yang Xie et al.
Background and objective: Ketorolac tromethamine (KT), a nonsteroidal anti-inflammatory drug (NSAID) and cyclooxygenase inhibitor, is commonly used for the management of moderate to severe pain. The objective of this stud...
Long-Xun Zhu,Yong Chen,Xiang-Fan Chen et al. Long-Xun Zhu et al.
Background and objectives: Acute pancreatitis (AP) is a serious disease characterized by local inflammatory responses in the pancreas. The annual incidence rate of acute pancreatitis is 4.9-73.4 per 100,000 people. Among ...